Saponin Inc is a plant biopharmaceutical firm operating out of the National Research Counsel (NRC) of Canada's Plant Biotechnology Institute in Saskatoon, Saskatchewan, Canada. In conjunction with the NRC and also Agriculture and Agri-Food Canada, the company is commercialising Prairie CarnationTM as a new health and nutrition crop.
Saponin's research activities through the Prairie CarnationTM value chain are protected by a portfolio of patents, patents pending and exclusive licensing agreements. The firm's intellectual property platform provides for multiple novel ingredients and products, including an extremely fine granule starch, and several families of unique bioactive saponins and cyclopeptides. This unique situation provides the basis for a number of different businesses and partnering strategies.
The company aims to generate early cash flow from its adjuvant, microstarch ingredient and product businesses in order to underpin drug discovery activites. Saponin's will harvest significant capital gains through liquidity events presented by the wide ranging Saponin IP platform and value chain.
Saponin has several compounds at the
"proof-of-concept" and pre-clinical stages as vacinne adjuvants. The firm is
assessing several compounds for their bioactivity with respect to cancer and
cardiovascular disease.
To find out more please join us at the Table.